Phase II study of S-1 plus Bevacizumab combination chemotherapy for patients with non-small-cell lung cancer.
Phase 2
- Conditions
- lung cancer
- Registration Number
- JPRN-UMIN000004677
- Lead Sponsor
- Shinshu University thoracic surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
Not provided
Exclusion Criteria
Besides the above
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method